Search

Your search keyword '"Jørgensen, Marit E."' showing total 913 results

Search Constraints

Start Over You searched for: Author "Jørgensen, Marit E." Remove constraint Author: "Jørgensen, Marit E."
913 results on '"Jørgensen, Marit E."'

Search Results

104. 491-P: Severe Muscle Insulin Resistance in Inuit Homozygous Carriers of the Common Greenlandic P.Arg684Ter TBC1D4 Variant Is Improved by a Single Bout of Exercise

105. Food Preferences in a Greenlandic Population

106. Additional file 2 of Genome-wide association study of circulating levels of glucagon during an oral glucose tolerance test

107. Additional file 1 of Cardiovascular outcomes with sodium–glucose cotransporter-2 inhibitors vs other glucose-lowering drugs in 13 countries across three continents: analysis of CVD-REAL data

108. Towards precision medicine in diabetes? A critical review of glucotypes

109. The trans-ancestral genomic architecture of glycemic traits

110. The effects of dapagliflozin, metformin or exercise on glycaemic variability in overweight or obese individuals with prediabetes (the PRE-D Trial):a multi-arm, randomised, controlled trial

111. Trajectories of Childhood Adversity and Type 1 Diabetes:A Nationwide Study of One Million Children

112. Response to Comment on Vistisen et al. A validated prediction model for endstage kidney disease in type 1 diabetes. Diabetes care 2021;44:901–907

113. The genetic history of Greenlandic-European contact

114. A Validated Prediction Model for End-Stage Kidney Disease in Type 1 Diabetes

115. Diabetic Polyneuropathy Early in Type 2 Diabetes Is Associated With Higher Incidence Rate of Cardiovascular Disease: Results From Two Danish Cohort Studies

116. Response to Comment on Vistisen et al. A Validated Prediction Model for End-Stage Kidney Disease in Type 1 Diabetes. Diabetes Care 2021;44:901–907

117. Plasma lipid metabolites associate with diabetic polyneuropathy in a cohort with type 2 diabetes

118. The genetic history of Greenlandic-European contact

119. Towards precision medicine in diabetes? A critical review of glucotypes

120. SMIM1absence is associated with reduced energy expenditure and excess weight

121. Discovery of rare variants associated with blood pressure regulation through meta-analysis of 1.3 million individuals.

122. The derived allele of a novel intergenic variant at chromosome 11 associates with lower body mass index and a favorable metabolic phenotype in Greenlanders

123. Accumulation of childhood adversities and type 1 diabetes risk:a register-based cohort study of all children born in Denmark between 1980 and 2015

124. Protocol for a single-centre, parallel-group, randomised, controlled, superiority trial on the effects of time-restricted eating on body weight, behaviour and metabolism in individuals at high risk of type 2 diabetes:the REStricted Eating Time (RESET) study

125. Metformin may adversely affect orthostatic blood pressure recovery in patients with type 2 diabetes:Substudy from the placebo-controlled Copenhagen Insulin and Metformin Therapy (CIMT) trial

126. Role of fasting duration and weekday in incretin and glucose regulation

136. No effects of dapagliflozin, metformin or exercise on plasma glucagon concentrations in individuals with prediabetes: A post hoc analysis from the randomized controlled PRE‐D trial

137. The effects of dapagliflozin, metformin or exercise on glycaemic variability in overweight or obese individuals with prediabetes (the PRE-D Trial): a multi-arm, randomised, controlled trial

139. Protocol for a single-centre, parallel-group, randomised, controlled, superiority trial on the effects of time-restricted eating on body weight, behaviour and metabolism in individuals at high risk of type 2 diabetes: the REStricted Eating Time (RESET) study

140. The Trans-Ancestral Genomic Architecture of Glycaemic Traits

141. Risk of cardiovascular events and death associated with initiation of SGLT2 inhibitors compared with DPP-4 inhibitors: an analysis from the CVD-REAL 2 multinational cohort study

142. 844-P: Effects of Dapagliflozin, Metformin, or Exercise on Plasma Glucagon Concentrations in Individuals with Prediabetes: The PRE-D Trial

144. 1615-P: Predicting End-Stage Kidney Disease in Type 1 Diabetes

147. 246-OR: A Loss-of-Function Mutation in the Sucrase-Isomaltase Gene Is Linked to a Markedly Healthier Metabolic Profile in Greenlanders

Catalog

Books, media, physical & digital resources